Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Inarigivir Soproxil + TAF in Chronic Hepatitis B
NCT03434353Phase 2Terminated
- Sponsor
- Gilead Sciences
- Start
- Feb 2018
- Primary completion
- Jan 2020
- Modality
- Small Molecules
- Countries
- 2
01
Overview
A Phase 2 trial of inarigivir soproxil in Chronic Hepatitis B (CHB), sponsored by Gilead Sciences. Started Feb 2018; status: terminated.
02
Drugs
inarigivir soproxil
03
Conditions
Chronic Hepatitis B (CHB)
Beyond the preview
Go deeper on NCT03434353.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03434353.